The efficacy of 2 doses of intrathecal morphine for analgesia after hepatic resection

The efficacy of 2 doses of intrathecal morphine for analgesia after hepatic resection: A randomized double blinded non-inferiority trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005126

Enrollment

Registered

2020-06-15

Start date

2020-06-22

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Before anesthesia for hepatic resection, the patient is turned to lateral position. After disinfection of the back, 200 mcg or 400 mcg intrathecal morphine is injected once at L3-4 intervertebr

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patients who is the American Society of Anesthesiologist classification 1 or 2 and undergoes open hepatic resection under general anesthesia between 19 and 60 years old.

Exclusion criteria

Exclusion criteria: Patient who have a known allergy to morphine, bleeding diathesis, neurologic dysfunction, recent systemic or local infections, history of drug use, or being treated with opioids due to chronic pain

Design outcomes

Primary

Measure	Time frame
Visual analog scale for postoperative pain at rest and when coughing	—

Secondary

Measure	Time frame
IV-PCA comsumption, use of other analgesics;hypotension;Postdural puncture headache, radicular back pain, muscle weakness, sensory deficit, the time to first flatus after surgery, the time to removal of foley catheter after surgery, the time to ambulation after surgery	—

Countries

Korea, Republic of

Contacts

Public ContactHa Yeon Kim

Ajou University Hospital

Outcome results